Hypertrophy and inflammation: Too much for one heart

European Heart Journal

Volumn 28, Issue 6, 2007, Pages 661-663

  Bayes Genis, Antoni ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL INFILTRATION; DEFIBRILLATOR; DISEASE COURSE; EDITORIAL; GENERAL CONDITION DETERIORATION; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFLAMMATORY CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VIRUS GENOME; VIRUS MYOCARDITIS; VIRUS VIRULENCE;

CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; MYOCARDITIS;

EID: 33947306979     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm008     Document Type: Editorial

References (10)

1. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1-8.
2. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 2000;84:476-482.
3. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-1035.
4. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216-225.
5. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212-2218.
6. Frustaci A, Verardo R, Caldarulo M, Acconcia MC, Russo MA, Chimenti C. Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Eur Heart J 2007;28:733-740. First published on February 19, 2007, doi:10.1093/eurheartj/ehl525.
7. Maron BJ, Shen W-K, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-373.
8. Spririto P, Rapezzi C, Bellone P, Betocchi S, Autore C, Conte MR, Bezante GP, Bruzzi P. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation 1999;99:2132-2137.
9. Casas O, Bragos R, Riu PJ, Rosell J, Tresanchez M, Warren M, Rodriguez-Sinovas A, Carreno A, Cinca J. In vivo and in situ ischaemic tissue characterization using electrical impedance spectroscopy. Ann NY Acad Sci 1999;873:51-58.
10. Garcia-Bolao I, Macias A, Lopez B, Gonzalez A, Gavira JJ, Azcarate P, Alegria E, Diez J. A biomarker of myocardial fibrosis predicts long-term response to cardiac resynchronization therapy. J Am Coll Cardiol 2006;47:2335-2337.